No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Estring market is a subset of the Sexual and Reproductive Health Drugs market. It is composed of products that are used to treat vaginal atrophy, a condition that can cause discomfort during sexual intercourse. These products are typically administered in the form of a vaginal ring, which is inserted into the vagina and slowly releases a hormone over a period of time. This hormone helps to reduce the symptoms of vaginal atrophy, such as dryness, itching, and burning.
The Estring market is a growing segment of the Sexual and Reproductive Health Drugs market, with products being developed to meet the needs of women who suffer from this condition. Companies in this market include Allergan, Endoceutics, and Teva Pharmaceuticals. Show Less Read more
